Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 27, 2022

BUY
$1.66 - $2.64 $1,660 - $2,640
1,000 Added 3.23%
32,000 $53,000
Q2 2021

Jul 20, 2021

BUY
$2.7 - $3.81 $83,700 - $118,110
31,000 New
31,000 $103,000

Others Institutions Holding MBIO

About MUSTANG BIO, INC.


  • Ticker MBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,222,000
  • Market Cap $46.3M
  • Description
  • Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...
More about MBIO
Track This Portfolio

Track Emfo, LLC Portfolio

Follow Emfo, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emfo, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emfo, LLC with notifications on news.